Printer Friendly
The Free Library
5,673,733 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

SRI International Announces New Manager of Operations for Quality Clinical Labs (QCL).


MENLO PARK, Calif. -- SRI International, an independent nonprofit research and development organization, announced today that Caroline Satyadi has joined SRI as manager of operations for Quality Clinical Labs (QCL QCL Quantum Cascade Laser
QCL Quality Class Level
) in Mountain View, California For the census-designated place, see Mountain View, Contra Costa County, California. For other places called "Mountain View", see .
Mountain View is a city in Santa Clara County, in the U.S. state of California. The city gets its name from the views of the Santa Cruz Mountains.
.

QCL was acquired by SRI in April 2006, and is the only commercial laboratory of its type in the state performing clinical pathology analyses in compliance with Good Laboratory Practice (GLP See gateway location protocol. ) regulations. QCL specializes in clinical hematology and chemistry evaluations, which are a key component of the preclinical safety studies required by the U.S. FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 in the development of new drugs. The company serves approximately 50 biotechnology and pharmaceutical clients throughout the San Francisco Bay area “Bay Area” redirects here. For other uses, see Bay Area (disambiguation).

The San Francisco Bay Area, colloquially known as the Bay Area or The Bay
.

At SRI, Ms. Satyadi will be responsible for the day to day operations of the lab including supervision of all staff, technical oversight, liaison with clients, and interfacing with SRI's Quality Assurance Unit to assure compliance with Good Laboratory Practice regulations.

Prior to joining SRI, Ms. Satyadi served as director of laboratory services at Colusa Regional Medical Center in Colusa, California. She has also served as manager of laboratories at IMPATH, NAMSA NAMSA NATO Maintenance and Supply Agency , and MDS MDS,
n See temporomandibular pain-dysfunction syndrome.

MDS 1 Maternal deprivation syndrome, see there 2 Myelodysplastic syndrome, see there
 Diagnostic Laboratories and as a research biostatistician for USC An abbreviation for U.S. Code.  School of Medicine.

"We are very pleased that Caroline has joined the QCL team at SRI," said Jon Mirsalis, Ph.D., D.A.B.T., managing director of SRI International's Biosciences Division. "Her impressive credentials and nearly 20 years of experience managing clinical laboratories will be a strong asset as we provide SRI clients and partners with the safety studies required to move drugs closer to the clinic and the marketplace."

Ms. Satyadi has a B.S. degree in medical microbiology, an M.S. in biostatistics, an M.B.A., and certifications as a medical technologist, specialist in microbiology, diplomate dip·lo·mate
n.
One who has received a diploma, especially a physician certified as a specialist by a board of examiners.


diplomate
(dip´l
 in laboratory management and specialist in laboratory safety (all ASCP ASCP American Society of Clinical Pathologists. ), certification and license as a Clinical Laboratory Scientist (NCA and State of California).

About SRI's Biosciences Division

SRI International's Biosciences Division is an organization of approximately 200 people with all of the resources necessary to take biological and chemical research programs from "idea to IND"[TM] - from initial discovery to investigational new drug applications to start human clinical trials. SRI Biosciences is a unique organization: it conducts basic research like a university, performs drug discovery and develops biologics like a biotechnology company, and is a contract research organization (CRO) that offers a full range of preclinical development and pharmaceutical sciences services. SRI Biosciences specializes in cancer, immunology, infectious disease, and neurosciences research.

To date, SRI has developed nine drugs internally that have entered clinical trials, with several more currently undergoing preclinical evaluation. Marketed examples of these drugs include bexarotene and halofantrine. Additionally, working with government and industry partners, SRI has helped advance more than 100 drugs into clinical trials, and more than 30 drugs onto the market. Through collaborations with other divisions at SRI, Biosciences is also working at the interfaces of science to create technical platforms for the next generation of drug discovery and development in areas such as drug delivery, diagnostics, and systems biology.

About SRI International

Silicon Valley-based SRI International (www.sri.com) is one of the world's leading independent research and technology development organizations. Founded as Stanford Research Institute Stanford Research Institute - Former name of SRI International.  in 1946, SRI has been meeting the strategic needs of clients for 60 years. The nonprofit research institute performs client-sponsored research and development for government agencies, commercial businesses, and private foundations. In addition to conducting contract R&D, SRI licenses its technologies, forms strategic partnerships, and creates spin-off companies.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 13, 2007
Words:585
Previous Article:Strix Systems Gets Strategic Investment From Samsung.
Next Article:University Infrastructure Spending Continues to Increase in 2007, an Industrial Info News Alert.
Topics:



Related Articles
By the numbers: a data bank on education trends for district leaders: this month: PDAS.(personal digital assistants)
Biotechnology and Pharmaceutical Executives to Convene at SRI International Innovation Forum in Tokyo; SRI Seeks to Collaborate With Japanese...
SRI International Launches Center of Excellence in Infectious Disease and Biodefense; Interdisciplinary Center to Advance Biotechnology Research for...
SRI International Acquires Quality Clinical Labs (QCL).
Pacific Biometrics, Inc. Hires David W. Swezey as New Lab Manager; Mr. Swezey Brings 25 Years of Management Experience in Clinical Laboratories.
Krishna Kodukula Joins SRI International's Biosciences Division.
SRI International Biosciences Executives to Present Seminar on Commercialization of Drug Discovery.
SRI International and LOGIIC Consortium Provide Critical Technical Support to Improve the Security of U.S. Oil and Gas Infrastructure.
SRI International Awarded a Multimillion Dollar Contract from the National Institute of Allergy and Infectious Diseases.
SRI International Awarded Contract From National Institute of Neurological Disorders and Stroke to Develop Chemical Agent Countermeasures.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles